abstract |
The object is to further enhance the anti-tumor effect when oxaliplatin is used in combination with a mixed preparation containing tegafur, gimeracil and oteracil potassium. By using oxaliplatin in the form of a liposome preparation, when the liposome preparation is used in combination with a mixed preparation containing tegafur, gimeracil and oteracil potassium, the anti-tumor effect can be significantly enhanced without increasing adverse side effects. |